The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Blood Plasma Derivatives Market Research Report 2024

Global Blood Plasma Derivatives Market Research Report 2024

Publishing Date : Jun, 2023

License Type :
 

Report Code : 1806573

No of Pages : 101

Ask Your Query

Blood plasma is the liquid component of blood constituting of water along with plasma components such as immunoglobulin, electrolytes, glucose, clotting factors, electrolytes, and hormones. It plays a crucial role in maintaining the electrolyte and osmotic balance while preventing infection and blood disorders in the body. Plasma derivatives are the concentrates of specific proteins, which require pooling of plasma from large number of donors. For instance, they require more than hundred plasma donations to produce sufficient immunoglobulin to treat an immune-deficient patient for one year. They are obtained by the process of fractionation where protein concentrates are separated and then clinically used.

Global Blood Plasma Derivatives market is projected to reach US$ 47030 million in 2029, increasing from US$ 30890 million in 2022, with the CAGR of 5.7% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Blood Plasma Derivatives market research.

The growth of the global blood plasma derivatives market is majorly driven by increase in prevalence of life-threatening disorders, especially hemophilia. Other factors boosting the market growth include rise in adoption of blood plasma derivatives products, upsurge in geriatric population across the world, and increase in awareness about blood & plasma donation. However, factors such as high cost of plasma derivative-based therapy and post-operative risks associated with plasma replacement therapy hamper the market growth. Conversely, the development of enhanced methods for preservation of plasma derivatives along with advanced procedures for fractionation and high potential in untapped markets in the emerging economies are expected to provide lucrative growth opportunities for the market.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Blood Plasma Derivatives market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

  •     Grifols
  •     SK Plasma
  •     Fusion Health Care
  •     Biotest AG
  •     Green Cross Corporation
  •     Baxter International
  •     LFB
  •     Octapharma AG
  •     CSL Limited
  •     Takeda
  •     China Biologic Products
  •     Kedrion Biopharma
  •     BDI Pharma
  •     Bayer AG
  •     Hualan Biological Engineering

Segment by Type

  •     Albumin
  •     Factor VIII
  •     Factor IX
  •     Immunoglobulin
  •     Hyperimmune Globulin
  •     Others

Segment by Application

  •     Hospitals
  •     Clinics
  •     Other End Users

By Region

  •  North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

Core Chapters

The Blood Plasma Derivatives report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies' Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source

 1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Blood Plasma Derivatives Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
        1.2.2 Albumin
        1.2.3 Factor VIII
        1.2.4 Factor IX
        1.2.5 Immunoglobulin
        1.2.6 Hyperimmune Globulin
        1.2.7 Others
    1.3 Market by Application
        1.3.1 Global Blood Plasma Derivatives Market Growth by Application: 2018 VS 2022 VS 2029
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Other End Users
    1.4 Study Objectives
    1.5 Years Considered
    1.6 Years Considered

 2 Global Growth Trends
    2.1 Global Blood Plasma Derivatives Market Perspective (2018-2029)
    2.2 Blood Plasma Derivatives Growth Trends by Region
        2.2.1 Global Blood Plasma Derivatives Market Size by Region: 2018 VS 2022 VS 2029
        2.2.2 Blood Plasma Derivatives Historic Market Size by Region (2018-2023)
        2.2.3 Blood Plasma Derivatives Forecasted Market Size by Region (2024-2029)
    2.3 Blood Plasma Derivatives Market Dynamics
        2.3.1 Blood Plasma Derivatives Industry Trends
        2.3.2 Blood Plasma Derivatives Market Drivers
        2.3.3 Blood Plasma Derivatives Market Challenges
        2.3.4 Blood Plasma Derivatives Market Restraints

 3 Competition Landscape by Key Players
    3.1 Global Top Blood Plasma Derivatives Players by Revenue
        3.1.1 Global Top Blood Plasma Derivatives Players by Revenue (2018-2023)
        3.1.2 Global Blood Plasma Derivatives Revenue Market Share by Players (2018-2023)
    3.2 Global Blood Plasma Derivatives Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Blood Plasma Derivatives Revenue
    3.4 Global Blood Plasma Derivatives Market Concentration Ratio
        3.4.1 Global Blood Plasma Derivatives Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Blood Plasma Derivatives Revenue in 2022
    3.5 Blood Plasma Derivatives Key Players Head office and Area Served
    3.6 Key Players Blood Plasma Derivatives Product Solution and Service
    3.7 Date of Enter into Blood Plasma Derivatives Market
    3.8 Mergers & Acquisitions, Expansion Plans

 4 Blood Plasma Derivatives Breakdown Data by Type
    4.1 Global Blood Plasma Derivatives Historic Market Size by Type (2018-2023)
    4.2 Global Blood Plasma Derivatives Forecasted Market Size by Type (2024-2029)

 5 Blood Plasma Derivatives Breakdown Data by Application
    5.1 Global Blood Plasma Derivatives Historic Market Size by Application (2018-2023)
    5.2 Global Blood Plasma Derivatives Forecasted Market Size by Application (2024-2029)

 6 North America
    6.1 North America Blood Plasma Derivatives Market Size (2018-2029)
    6.2 North America Blood Plasma Derivatives Market Growth Rate by Country: 2018 VS 2022 VS 2029
    6.3 North America Blood Plasma Derivatives Market Size by Country (2018-2023)
    6.4 North America Blood Plasma Derivatives Market Size by Country (2024-2029)
    6.5 United States
    6.6 Canada

 7 Europe
    7.1 Europe Blood Plasma Derivatives Market Size (2018-2029)
    7.2 Europe Blood Plasma Derivatives Market Growth Rate by Country: 2018 VS 2022 VS 2029
    7.3 Europe Blood Plasma Derivatives Market Size by Country (2018-2023)
    7.4 Europe Blood Plasma Derivatives Market Size by Country (2024-2029)
    7.5 Germany
    7.6 France
    7.7 U.K.
    7.8 Italy
    7.9 Russia
    7.10 Nordic Countries

 8 Asia-Pacific
    8.1 Asia-Pacific Blood Plasma Derivatives Market Size (2018-2029)
    8.2 Asia-Pacific Blood Plasma Derivatives Market Growth Rate by Region: 2018 VS 2022 VS 2029
    8.3 Asia-Pacific Blood Plasma Derivatives Market Size by Region (2018-2023)
    8.4 Asia-Pacific Blood Plasma Derivatives Market Size by Region (2024-2029)
    8.5 China
    8.6 Japan
    8.7 South Korea
    8.8 Southeast Asia
    8.9 India
    8.10 Australia

 9 Latin America
    9.1 Latin America Blood Plasma Derivatives Market Size (2018-2029)
    9.2 Latin America Blood Plasma Derivatives Market Growth Rate by Country: 2018 VS 2022 VS 2029
    9.3 Latin America Blood Plasma Derivatives Market Size by Country (2018-2023)
    9.4 Latin America Blood Plasma Derivatives Market Size by Country (2024-2029)
    9.5 Mexico
    9.6 Brazil

 10 Middle East & Africa
    10.1 Middle East & Africa Blood Plasma Derivatives Market Size (2018-2029)
    10.2 Middle East & Africa Blood Plasma Derivatives Market Growth Rate by Country: 2018 VS 2022 VS 2029
    10.3 Middle East & Africa Blood Plasma Derivatives Market Size by Country (2018-2023)
    10.4 Middle East & Africa Blood Plasma Derivatives Market Size by Country (2024-2029)
    10.5 Turkey
    10.6 Saudi Arabia
    10.7 UAE

 11 Key Players Profiles
    11.1 Grifols
        11.1.1 Grifols Company Detail
        11.1.2 Grifols Business Overview
        11.1.3 Grifols Blood Plasma Derivatives Introduction
        11.1.4 Grifols Revenue in Blood Plasma Derivatives Business (2018-2023)
        11.1.5 Grifols Recent Development
    11.2 SK Plasma
        11.2.1 SK Plasma Company Detail
        11.2.2 SK Plasma Business Overview
        11.2.3 SK Plasma Blood Plasma Derivatives Introduction
        11.2.4 SK Plasma Revenue in Blood Plasma Derivatives Business (2018-2023)
        11.2.5 SK Plasma Recent Development
    11.3 Fusion Health Care
        11.3.1 Fusion Health Care Company Detail
        11.3.2 Fusion Health Care Business Overview
        11.3.3 Fusion Health Care Blood Plasma Derivatives Introduction
        11.3.4 Fusion Health Care Revenue in Blood Plasma Derivatives Business (2018-2023)
        11.3.5 Fusion Health Care Recent Development
    11.4 Biotest AG
        11.4.1 Biotest AG Company Detail
        11.4.2 Biotest AG Business Overview
        11.4.3 Biotest AG Blood Plasma Derivatives Introduction
        11.4.4 Biotest AG Revenue in Blood Plasma Derivatives Business (2018-2023)
        11.4.5 Biotest AG Recent Development
    11.5 Green Cross Corporation
        11.5.1 Green Cross Corporation Company Detail
        11.5.2 Green Cross Corporation Business Overview
        11.5.3 Green Cross Corporation Blood Plasma Derivatives Introduction
        11.5.4 Green Cross Corporation Revenue in Blood Plasma Derivatives Business (2018-2023)
        11.5.5 Green Cross Corporation Recent Development
    11.6 Baxter International
        11.6.1 Baxter International Company Detail
        11.6.2 Baxter International Business Overview
        11.6.3 Baxter International Blood Plasma Derivatives Introduction
        11.6.4 Baxter International Revenue in Blood Plasma Derivatives Business (2018-2023)
        11.6.5 Baxter International Recent Development
    11.7 LFB
        11.7.1 LFB Company Detail
        11.7.2 LFB Business Overview
        11.7.3 LFB Blood Plasma Derivatives Introduction
        11.7.4 LFB Revenue in Blood Plasma Derivatives Business (2018-2023)
        11.7.5 LFB Recent Development
    11.8 Octapharma AG
        11.8.1 Octapharma AG Company Detail
        11.8.2 Octapharma AG Business Overview
        11.8.3 Octapharma AG Blood Plasma Derivatives Introduction
        11.8.4 Octapharma AG Revenue in Blood Plasma Derivatives Business (2018-2023)
        11.8.5 Octapharma AG Recent Development
    11.9 CSL Limited
        11.9.1 CSL Limited Company Detail
        11.9.2 CSL Limited Business Overview
        11.9.3 CSL Limited Blood Plasma Derivatives Introduction
        11.9.4 CSL Limited Revenue in Blood Plasma Derivatives Business (2018-2023)
        11.9.5 CSL Limited Recent Development
    11.10 Takeda
        11.10.1 Takeda Company Detail
        11.10.2 Takeda Business Overview
        11.10.3 Takeda Blood Plasma Derivatives Introduction
        11.10.4 Takeda Revenue in Blood Plasma Derivatives Business (2018-2023)
        11.10.5 Takeda Recent Development
    11.11 China Biologic Products
        11.11.1 China Biologic Products Company Detail
        11.11.2 China Biologic Products Business Overview
        11.11.3 China Biologic Products Blood Plasma Derivatives Introduction
        11.11.4 China Biologic Products Revenue in Blood Plasma Derivatives Business (2018-2023)
        11.11.5 China Biologic Products Recent Development
    11.12 Kedrion Biopharma
        11.12.1 Kedrion Biopharma Company Detail
        11.12.2 Kedrion Biopharma Business Overview
        11.12.3 Kedrion Biopharma Blood Plasma Derivatives Introduction
        11.12.4 Kedrion Biopharma Revenue in Blood Plasma Derivatives Business (2018-2023)
        11.12.5 Kedrion Biopharma Recent Development
    11.13 BDI Pharma
        11.13.1 BDI Pharma Company Detail
        11.13.2 BDI Pharma Business Overview
        11.13.3 BDI Pharma Blood Plasma Derivatives Introduction
        11.13.4 BDI Pharma Revenue in Blood Plasma Derivatives Business (2018-2023)
        11.13.5 BDI Pharma Recent Development
    11.14 Bayer AG
        11.14.1 Bayer AG Company Detail
        11.14.2 Bayer AG Business Overview
        11.14.3 Bayer AG Blood Plasma Derivatives Introduction
        11.14.4 Bayer AG Revenue in Blood Plasma Derivatives Business (2018-2023)
        11.14.5 Bayer AG Recent Development
    11.15 Hualan Biological Engineering
        11.15.1 Hualan Biological Engineering Company Detail
        11.15.2 Hualan Biological Engineering Business Overview
        11.15.3 Hualan Biological Engineering Blood Plasma Derivatives Introduction
        11.15.4 Hualan Biological Engineering Revenue in Blood Plasma Derivatives Business (2018-2023)
        11.15.5 Hualan Biological Engineering Recent Development

 12 Analyst's Viewpoints/Conclusions

 13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

Published By : 9Dimen Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock